PROFENAL by Alcon is clinical pharmacology suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. First approved in 1988.
Drug data last refreshed 16h ago · AI intelligence enriched 4w ago
PROFENAL (suprofen) is a phenylalkanoic acid NSAID formulated as an ophthalmic solution that inhibits cyclooxygenase to suppress prostaglandin-mediated intraocular inflammation. It is indicated to inhibit miosis (pupil constriction) during cataract surgery by blocking prostaglandin-induced iris sphincter constriction. The drug delivers targeted anti-inflammatory activity to the eye with minimal systemic absorption.
As a mature ophthalmic surgical adjunct approaching loss of exclusivity, the PROFENAL brand team is likely small and focused on defense against generics and competitive NSAIDs.
CLINICAL PHARMACOLOGY Suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. Its mechanism of action is believed to be through inhibition of the cyclooxygenase enzyme that is essential in the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on PROFENAL at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
PROFENAL is a career-defensive opportunity suited for professionals in commercial execution, market access, and regulatory compliance during a LOE transition. Working on this product offers experience in generic defense strategies and niche market management rather than growth-stage innovation.